why choose us

First received: November 9, 2022

Clinical Trial: Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

Study Status: Completed

Recruit Status: Completed

Condition: type1diabetes

Study Type: Observational


Official Title: Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in Adolescents With Type 1 Diabetes: A Prospective Observational Study

Brief Summary: Adolescents with type 1 diabetes may be at increased risk for severe coronavirus disease-2019 (COVID-19) and are therefore prioritized for access to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. The pivotal trial that assessed the efficacy of the BNT162b2 vaccine among adolescents demonstrated 100% protection against SARS-CoV-2 infection after a two-dose regimen. However, the research did not include adolescents with type 1 diabetes. In this study, the investigators aimed to assess the…

Read more